Skip to content

Cell BioEngines, Inc vs Wugen

Cell BioEngines, Inc logo

Cell BioEngines, Inc

‘Off-the-Shelf’ Curative Cell Therapies

3 employees · est. 2022 · New York, United States

VS
Wugen logo

Wugen

Engineering the Next Generation of Off-the-Shelf Cell Therapies

51 employees · est. 2018 · St. Louis, United States

Wugen is the older company (2022 vs 2018); Wugen is the larger of the two.

Side-by-Side Comparison

Cell BioEngines, Inc Wugen
Founded
2022 2018 older
Headquarters
New York, United States St. Louis, United States
Employees
3 51 larger
Industry
Biotechnology, Health and Wellness Biotechnology, Health and Wellness
Funding Stage
Pre-Seed Series C
Total Funding
$1.38M $323.00M
Funding Rounds
5 5
Taxonomy
Cell BioEnginesBiotech CompanyAllogenic Cell TherapiesStem-SPACE PlatformCancer CureClinical-Stage +9 Cell TherapyOff-the-shelfNK CellsCAR-T CellsCancerMoneta Platform +8
Website
cellbioengines.com wugen.com
Cell BioEngines, Inc logo

About Cell BioEngines, Inc

Cell BioEngines, Inc is a clinical-stage biotech company that aims to revolutionize cancer treatment through the development of 'off-the-shelf' allogenic cell therapies. The company leverages its proprietary Stem-SPACE platform technology to produce clinical-grade cells at scale from 'non-gene-modif...

Wugen logo

About Wugen

Wugen is a clinical-stage biotechnology company with the slogan "Engineering the Next Generation of Off-the-Shelf Cell Therapies." Founded in 2018, the company is based out of St. Louis, Missouri and San Diego, California. Wugen is focused on developing off-the-shelf memory natural killer (NK) and C...

Also comparing in this category

Comparing more than these two?

Get Cell BioEngines, Inc, Wugen and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Cell BioEngines, Inc compare?

A PDF of Cell BioEngines, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Cell BioEngines, Inc was founded in 2022, based in New York, United States, with 3 employees. Cell BioEngines, Inc is a clinical-stage biotech company that aims to revolutionize cancer treatment through the development of 'off-the-shelf' allogenic cell therapies. The company leverages its prop. Wugen was founded in 2018, based in St. Louis, United States, with 51 employees. Wugen is a clinical-stage biotechnology company with the slogan "Engineering the Next Generation of Off-the-Shelf Cell Therapies." Founded in 2018, the company is based out of St. Louis, Missouri and.
Cell BioEngines, Inc has raised $1.38M and Wugen $323.00M. Latest stage: Cell BioEngines, Inc Pre-Seed, Wugen Series C.
Both work in Biotechnology and Health and Wellness and list clinical-stage and cell therapy among their focus areas.

Compare Cell BioEngines, Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cell BioEngines, Inc on 12 Sep 2024, and Wugen on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout